Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
33
pubmed:dateCreated
2004-8-9
pubmed:abstractText
We show herein that removal of the first 86 amino acids (aa) of the N terminus (designated N) of type VI adenylyl cyclase (ACVI) caused the resultant ACVI mutant (ACVI-DeltaA87) to be more greatly inhibited by a Galpha(i)-coupled receptor or activated Galpha(i) protein. Moreover, in vitro binding of the full-length N and C1a domain (designated C1a), which interacts with Galpha(i), was detected. A truncated N terminus (aa 1-86) also interacted with C1a, suggesting that the C1a-interacting region is located within aa 1-86. Mutation analyses further revealed that N might interact with C1a in the region (aa 434-505) where Galpha(i) is bound. Mutations of two residues (Leu-472 and Val-476) located in this N-binding region of C1a suppressed the interaction between recombinant N and C1a and markedly reduced Galpha(i)-mediated inhibition of ACVI-DeltaA87. Further biochemical analyses of the effect of internal mutations of Leu-472/Val-476 on Galpha(i)-mediated inhibition of wild-type ACVI and ACVI-DeltaA87 suggested that N modulates the Galpha(i)-mediated inhibition of ACVI via binding to C1a when the level of Galpha(i) is low (i.e. around the IC(50) value) and that a more complicated interfering mode results when the level of Galpha(i) is high (i.e. approximately 10- to 20-fold of the IC(50) value). Collectively, data presented herein suggest a novel function of the N terminus of ACVI in Galpha(i)-mediated regulation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
279
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
34440-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15192109-Adenylate Cyclase, pubmed-meshheading:15192109-Animals, pubmed-meshheading:15192109-Blotting, Western, pubmed-meshheading:15192109-CHO Cells, pubmed-meshheading:15192109-Catalytic Domain, pubmed-meshheading:15192109-Cell Line, pubmed-meshheading:15192109-Cell Membrane, pubmed-meshheading:15192109-Cricetinae, pubmed-meshheading:15192109-Dose-Response Relationship, Drug, pubmed-meshheading:15192109-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:15192109-GTP-Binding Protein alpha Subunit, Gi2, pubmed-meshheading:15192109-GTP-Binding Protein alpha Subunits, Gi-Go, pubmed-meshheading:15192109-Humans, pubmed-meshheading:15192109-Inhibitory Concentration 50, pubmed-meshheading:15192109-Leucine, pubmed-meshheading:15192109-Models, Biological, pubmed-meshheading:15192109-Models, Molecular, pubmed-meshheading:15192109-Mutagenesis, Site-Directed, pubmed-meshheading:15192109-Mutation, pubmed-meshheading:15192109-Plasmids, pubmed-meshheading:15192109-Polymerase Chain Reaction, pubmed-meshheading:15192109-Protein Binding, pubmed-meshheading:15192109-Protein Conformation, pubmed-meshheading:15192109-Protein Isoforms, pubmed-meshheading:15192109-Protein Structure, Secondary, pubmed-meshheading:15192109-Protein Structure, Tertiary, pubmed-meshheading:15192109-Proto-Oncogene Proteins, pubmed-meshheading:15192109-Rats, pubmed-meshheading:15192109-Recombinant Proteins, pubmed-meshheading:15192109-Transfection, pubmed-meshheading:15192109-Valine
pubmed:year
2004
pubmed:articleTitle
An important functional role of the N terminus domain of type VI adenylyl cyclase in Galphai-mediated inhibition.
pubmed:affiliation
Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, ROC.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't